MXCT vs SLB · rev $38.6M vs P/E 12, rev $35.71B
MaxCyte Inc (MXCT) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
MXCT currently screens at market cap $124.3M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the MXCT and SLB stock pages for the full models.
Not investment advice.